Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, P. R. China; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, P. R. China.
Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, P. R. China; The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan 511518, P. R. China.
Acta Biomater. 2022 Oct 1;151:600-612. doi: 10.1016/j.actbio.2022.08.011. Epub 2022 Aug 9.
The depletion of reactive oxygen species (ROS) by glutathione (GSH) and oxidative stress induced protective autophagy severely impaired the therapeutic effect of chemodynamic therapy (CDT). Therefore, how to construct a CDT treatment nanosystem with high yield and full utilization of ROS in tumor site is the main issue of CDT. Herein, a multifunctional cascade bioreactor based on mesoporous Mo-doped CuS (m-MCS) nanozymes loaded with L-Arginine (LA), abbreviated as m-MCS@LA, is constructed for realizing enhanced CDT promoted by ultrasound (US) triggered gas therapy. The m-MCS based on the catalytic performance of multivalent metal ions, which were served as nanozymes, exhibit enhanced Fenton-like and glutathione (GSH) peroxidase-like activities in comparison to CuS nanoparticles without Mo-doping. Once placed in tumor microenvironment (TME), the existence of redox couples (Cu/Cu and Mo/Mo) in m-MCS enabled it to react with hydrogen peroxide (HO) to generate ·OH for achieving CDT effect via Fenton-like reaction. Meanwhile, m-MCS could consume overexpressed GSH in tumor microenvironment (TME) to alleviate antioxidant capability for enhancing CDT effect. Moreover, m-MCS with mesoporous structure could be employed as the carrier to load natural nitric oxide (NO) donor LA. US as the excitation source with high tissue penetration can trigger m-MCS@LA to produce NO. As the gas transmitter with physiological functions, NO could play dual roles to kill cancer cells through gas therapy directly, and enhance CDT effect by inhibiting protective autophagy simultaneously. As a result, this US-triggered and NO-mediated synergetic cancer chemodynamic/gas therapy based on m-MCS@LA NPs can effectively eliminate primary tumor and achieved tumor-specific treatment, which provide a possible strategy for developing more effective CDT in future practical applications. STATEMENT OF SIGNIFICANCE: The depletion of reactive oxygen species (ROS) by glutathione (GSH) and oxidative stress induced protective autophagy severely impaired the therapeutic effect of chemodynamic therapy (CDT). Herein, a multifunctional cascade bioreactor based on mesoporous Mo-doped CuS (m-MCS) nanozymes loaded with L-Arginine (m-MCS@LA) is constructed for realizing enhanced CDT promoted by ultrasound (US) triggered gas therapy. The m-MCS with double redox couples presents the enhanced enzyme-like activities to perform cascade reactions for reducing GSH and generating ROS. LA loaded by m-MCS can produce NO triggered by US to inhibit the mitochondria protective autophagy for reactivating mitochondria involved apoptosis pathway. The US-triggered and NO-mediated CDT based on m-MCS@LA can effectively eliminate primary tumor through the high yield and full utilization of ROS.
活性氧(ROS)的耗竭由谷胱甘肽(GSH)和氧化应激诱导的保护性自噬严重损害了化学动力学治疗(CDT)的治疗效果。因此,如何构建一种在肿瘤部位具有高产率和充分利用 ROS 的 CDT 治疗纳米系统是 CDT 的主要问题。在此,构建了一种基于介孔 Mo 掺杂 CuS(m-MCS)纳米酶负载 L-精氨酸(LA)的多功能级联生物反应器,简称 m-MCS@LA,用于实现超声(US)触发气体治疗增强的 CDT。基于多价金属离子催化性能的 m-MCS 作为纳米酶,与没有 Mo 掺杂的 CuS 纳米粒子相比,表现出增强的类 Fenton 和谷胱甘肽(GSH)过氧化物酶样活性。一旦置于肿瘤微环境(TME)中,m-MCS 中氧化还原对(Cu/Cu 和 Mo/Mo)的存在使其能够与过氧化氢(HO)反应生成·OH,通过类 Fenton 反应实现 CDT 效应。同时,m-MCS 可以消耗肿瘤微环境(TME)中超表达的 GSH,以减轻抗氧化能力,增强 CDT 效应。此外,具有介孔结构的 m-MCS 可用作载体来负载天然一氧化氮(NO)供体 LA。作为具有高组织穿透性的激发源的 US 可以触发 m-MCS@LA 产生 NO。作为具有生理功能的气体传递体,NO 可以直接通过气体治疗杀死癌细胞,同时通过抑制保护性自噬来增强 CDT 效应,发挥双重作用。因此,基于 m-MCS@LA NPs 的这种 US 触发和 NO 介导的协同癌症化学动力学/气体治疗可以有效消除原发性肿瘤并实现肿瘤特异性治疗,为未来实际应用中开发更有效的 CDT 提供了一种可能的策略。